Synthesis and in vitro binding studies of piperazine-alkyl-naphthamides: impact of homology and sulphonamide/carboxamide bioisosteric replacement on the affinity for 5-HT1A, alpha2A, D4.2, D3 and D2L receptors.
暂无分享,去创建一个
[1] Jessica Sallander,et al. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity. , 2009, Journal of medicinal chemistry.
[2] Bryan L. Roth,et al. WAY-100635 is a potent dopamine D4 receptor agonist , 2006, Psychopharmacology.
[3] H. Rhim,et al. Preparation of piperazine derivatives as 5-HT7 receptor antagonists. , 2008, Bioorganic & medicinal chemistry.
[4] B. Roth,et al. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia , 2004, Nature Reviews Drug Discovery.
[5] L. Callado,et al. Guanidine and 2-aminoimidazoline aromatic derivatives as alpha2-adrenoceptor ligands: searching for structure-activity relationships. , 2009, Journal of medicinal chemistry.
[6] P. Sokoloff,et al. N-(ω-(4-(2-Methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as Dopamine D2 and D3 Receptor Ligands , 2003 .
[7] B. Roth,et al. Synthesis and in vitro binding studies of substituted piperidine naphthamides. Part I: Influence of the substitution on the basic nitrogen and the position of the amide on the affinity for D2L, D4.2, and 5-HT2A receptors. , 2007, Bioorganic & medicinal chemistry letters.
[8] T. Svensson,et al. Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade. , 1999, Science.
[9] M. Kołaczkowski,et al. The impact of spacer structure on 5-HT7 and 5-HT1A receptor affinity in the group of long-chain arylpiperazine ligands. , 2004, Bioorganic & medicinal chemistry letters.
[10] C. Wermuth,et al. Comprar The Practice of Medicinal Chemistry, 3rd Edition | Camille G. Wermuth | 9780123741943 | Academic Press , 2009 .
[11] B. Everitt,et al. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist , 1999, Nature.
[12] H. Meltzer,et al. 5‐HT2A and D2 receptor blockade increases cortical DA release via 5‐HT1A receptor activation: a possible mechanism of atypical antipsychotic‐induced cortical dopamine release , 2001, Journal of neurochemistry.
[13] H. Rhim,et al. Synthesis and biological evaluation of (phenylpiperazinyl-propyl)arylsulfonamides as selective 5-HT(2A) receptor antagonists. , 2010, Bioorganic & medicinal chemistry.
[14] G. Dive,et al. New Alkoxypyridine-sulfonamides: Synthesis, Biological Evaluation, and Physicochemical Properties , 1991 .
[15] K. Wicke,et al. The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors. , 2001, European journal of pharmacology.
[16] Michael Williams,et al. Emerging opportunities for antipsychotic drug discovery in the postgenomic era. , 2008, Journal of medicinal chemistry.
[18] E. Novellino,et al. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors. , 2003, Journal of medicinal chemistry.
[19] Synthesis and in vitro binding studies of substituted piperidine naphthamides. Part II: Influence of the substitution on the benzyl moiety on the affinity for D2L, D4.2, and 5-HT2A receptors. , 2007, Bioorganic & medicinal chemistry letters.